Dr. Girish Sahni has assumed charge as the next Director General of the Council of Scientific & Industrial Research (CSIR) and Secretary, Department of Scientific & Industrial Research (DSIR). He had been the Director, CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh.
Girish Sahni
- Born on 2nd March 1956, Dr Sahni is a PhD from Indian institute of Science (IISc), Bengaluru.
- Dr. Sahni has contributed significantly in the area of protein cardiovascular drugs especially ‘clot busters’ and their mode of action in the human body.
- Dr Sahni’s team has developed a novel life-saver thrombolytic drug (Clot-specific streptokinase), India’s first bio-therapeutic molecule which is not a Biosimilar.
- Recently Dr Sahni’s team developed a fourth-generation ‘Anti-thrombotic’ clot busters – the first of its kind in the world.
- Dr. Sahni is internationally recognized for his research contributions.
- He has been the author of several papers published in high impact refereed scientific journals and has a number of national and international patents to his credit.
- He was conferred with many awards in his career. Some of those are National Biotechnology Product Development Award 2002, CSIR Technology Shield 2001-2002, Ranbaxy Award in Pharmaceutical Sciences 2003, Vigyan Rattan Award 2014, Shri Om Prakash Bhasin Award 2013, and CSIR Technology Award for Business Development and Technology Marketing 2014.
Tidbits
- Council of Scientific and Industrial Research (CSIR) established in 1942, is an autonomous body and India’s largest research and development (R&D) organisation.
- CSIR is mainly funded by the Ministry of Science and Technology.
- It operates as an autonomous body registered under the Registration of Societies Act of 1860.
Test Your Knowledge
Who was the first director-general of the Council of Scientific and Industrial Research (CSIR)?